Works matching IS 13524585 AND DT 2023 AND VI 29 AND IP 9
Results: 21
May Mediterranean diet contribute to reduce risk of multiple sclerosis?
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1045, doi. 10.1177/13524585231190342
- By:
- Publication type:
- Article
Enhancing involvement of people with multiple sclerosis in clinical trial design.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1162, doi. 10.1177/13524585231189678
- By:
- Publication type:
- Article
Enhancing diversity of clinical trial populations in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1174, doi. 10.1177/13524585231189677
- By:
- Publication type:
- Article
Intermediate outcomes for clinical trials of multiple sclerosis rehabilitation interventions: Conceptual and practical considerations.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1186, doi. 10.1177/13524585231189674
- By:
- Publication type:
- Article
Assessing heterogeneity of treatment effect in multiple sclerosis trials.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1158, doi. 10.1177/13524585231189673
- By:
- Publication type:
- Article
Improving the efficiency of clinical trials in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1136, doi. 10.1177/13524585231189671
- By:
- Publication type:
- Article
Participant diversity in clinical trials of rehabilitation interventions for people with multiple sclerosis: A scoping review.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1149, doi. 10.1177/13524585231189670
- By:
- Publication type:
- Article
Commentary: Solomon AJ et al. Differential diagnosis of suspected multiple sclerosis: An updated consensus approach. Lancet Neurol 2023; 22(8): 750–768.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1047, doi. 10.1177/13524585231188097
- By:
- Publication type:
- Article
Is Clostridium perfringens epsilon toxin associated with multiple sclerosis?
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1057, doi. 10.1177/13524585231186899
- By:
- Publication type:
- Article
Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1126, doi. 10.1177/13524585231181578
- By:
- Publication type:
- Article
Assessing everyday functional activity in cognitively impaired people with multiple sclerosis: The use of Actual Reality TM.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1107, doi. 10.1177/13524585231185048
- By:
- Publication type:
- Article
Quality of life should be the primary outcome for disease modifying therapy trials in MS—No.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1066, doi. 10.1177/13524585231182708
- By:
- Publication type:
- Article
Quality of life should be the primary outcome for disease-modifying therapy trials in MS—Yes.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1064, doi. 10.1177/13524585231182705
- By:
- Publication type:
- Article
Quality of life should be the primary outcome for disease-modifying therapy trials in MS: Commentary.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1068, doi. 10.1177/13524585231182702
- By:
- Publication type:
- Article
Inverse association between Mediterranean diet and risk of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1118, doi. 10.1177/13524585231181841
- By:
- Publication type:
- Article
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1080, doi. 10.1177/13524585231184738
- By:
- Publication type:
- Article
Coexistence of multiple sclerosis and spinocerebellar ataxia type-8.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1195, doi. 10.1177/13524585231180549
- By:
- Publication type:
- Article
Impact of COVID-19 vaccination or infection on disease activity in a radiologically isolated syndrome cohort: The VaxiRIS study.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1099, doi. 10.1177/13524585231179669
- By:
- Publication type:
- Article
Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1070, doi. 10.1177/13524585231176732
- By:
- Publication type:
- Article
Sars-CoV2 infection in pregnant women with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1090, doi. 10.1177/13524585231176174
- By:
- Publication type:
- Article
The Barancik lecture: Comorbidity in multiple sclerosis—Looking backward, looking forward.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 9, p. 1049, doi. 10.1177/13524585231167740
- By:
- Publication type:
- Article